dabigatran has been researched along with Heart Failure in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (3.13) | 29.6817 |
| 2010's | 20 (62.50) | 24.3611 |
| 2020's | 11 (34.38) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Z; Mao, J; Pan, J; Shen, Z; Shi, A; Su, C; Tao, H; Xu, F; Zhu, Z | 1 |
| Alvarez, P; Chaudhury, P; Desai, MY; Hanna, M; Kanj, M; Mentias, A; Moudgil, R; Nakhla, M | 1 |
| Alioğlu, E; Altın, C; Bilgin, N; Çetin, N; Dalgıç, O; Ekmekçi, C; Kocabaş, U; Özpelit, ME; Pekel, N; Topaloğlu, C; Tülüce, K; Tunçer, E; Türk, UÖ; Türkoğlu, Eİ; Yavuz, V; Yüksel, K | 1 |
| Cui, C; Jiang, Y; Li, H; Ling, J; Liu, D; Pan, J; Qu, Y; Sia, JEV; Wang, Y; Zhu, Z | 1 |
| Bergler-Klein, J; Chuquiure-Valenzuela, E; Diener, HC; Dubner, SJ; Halperin, J; Huisman, MV; Lip, GYH; Lu, S; Ma, CS; Paquette, M; Riou França, L; Rothman, KJ; Teutsch, C; Zint, K | 1 |
| Bonetti, B; Bovi, P; Bovi, T; Cappellari, M; Forlivesi, S; Micheletti, N; Musso, AM; Sajeva, G; Tomelleri, G; Valbusa, V; Zucchella, C | 1 |
| Jin, H; Wang, L; Zhi, H; Zhou, W; Zhu, K | 1 |
| Del Sole, F; Menichelli, D; Pastori, D; Pignatelli, P; Violi, F | 1 |
| Ghaznavi, Z; Jackevicius, CA; Lu, L; Warner, AL | 1 |
| Böhm, M; Brueckmann, M; Connolly, S; Eikelboom, JW; Ewen, S; Ezekowitz, M; Millenaar, D; Schumacher, H; Slawik, J; Ukena, C; Wallentin, L; Yusuf, S | 1 |
| Connor, DE; Hayward, CS; Jain, P; Jansz, P; Joseph, J; Kerr, NP; Muthiah, K; Rao, SD; Robson, D; Shehab, S | 1 |
| Bhave, PD; Bhise, V; Chaikriangkrai, K; Deshmukh, A; Giudici, M; Horwitz, PA; Inampudi, C; Kumar, AA; Mentias, A; Mickelsen, S; Oral, H; Palamaner Subash Shantha, G; Pancholy, S; Patel, N; Vaughan Sarrazin, MS | 1 |
| Fredgart, M; Gill, S | 1 |
| Droogne, W; Rega, F; Rex, S; Van Cleemput, J; Van Keer, JM; Vanassche, T; Verhamme, P | 1 |
| Gaudard, P; Kalmanovich, E; Roubille, F | 1 |
| Amin, A; Dhamane, A; Di Fusco, M; Friend, K; Garcia Reeves, AB; Keshishian, A; Li, X; Luo, X; Mardekian, J; Nadkarni, A; Pan, X; Rosenblatt, L; Yuce, H | 1 |
| Bergfeldt, L; Blomström-Lundqvist, C; Boriani, G; Botto, GL; Camm, AJ; Capucci, A; Goette, A; Hohnloser, SH; Israel, CW; Lozano, IF; Merino, JL | 1 |
| Andreev, DA; Gappoeva, ZK; Giliarov, MIu; Sychev, DA | 1 |
| Heidenreich, PA | 1 |
| Boos, CJ; Camm, AJ; Nam, M | 1 |
| Brueckmann, M; Connolly, SJ; Ezekowitz, MD; Ferreira, J; Fraessdorf, M; Reilly, PA; Wallentin, L; Yusuf, S | 1 |
| Eder, V; Haring, HP; Müller, P; Nesser, HJ; Nußbaumer, K; Sonnberger, M; Topakian, R; Trenkler, J; Windpessl, M | 1 |
| Lip, GY; Van Gelder, IC; Van Veldhuisen, DJ | 1 |
| Fosbøl, EL; Gislason, GH; Hansen, ML; Køber, L; Lamberts, M; Mikkelsen, AP; Olesen, JB; Sørensen, R; Torp-Pedersen, C; Weeke, P | 1 |
| Agirbasli, M; Atas, H; Bozbay, M; Cincin, A; Dogan, Z; Oguz, M; Sunbul, M | 1 |
| Granger, CB; Hawkins, NM; Jhund, PS; McMurray, JJ; O'Meara, E; Petrie, MC; Pfeffer, MA; Pozzi, A; Solomon, SD; Swedberg, K; Virani, S; Yusuf, S | 1 |
| Buck, J; Cram, P; Gage, BF; Kaboli, P; Vaughan Sarrazin, MS | 1 |
| Dellegrottaglie, S; Filippatos, G; Giugliano, RP; Lund, LH; Magnani, G; McMurray, J; Perrone-Filardi, P; Rosano, GM; Savarese, G; Trimarco, B | 1 |
| Barcellona, D; Cianchetti, ME; Mameli, A; Marongiu, F; Musu, M; Porru, M; Ruberto, MF; Schirru, P | 1 |
| Boos, CJ; Brown, LAE | 1 |
| EncisoSilva, J; Greenberg, B; Schlueter, M; Thomas, I | 1 |
| Nendaz, M; Perrier, A | 1 |
6 review(s) available for dabigatran and Heart Failure
| Article | Year |
|---|---|
Efficacy and safety of non-vitamin K anticoagulants and warfarin in patients with atrial fibrillation and heart failure: A network meta-analysis.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Heart Failure; Humans; Network Meta-Analysis; Pyridones; Rivaroxaban; Stroke; Warfarin | 2020 |
Safety and efficacy of dronedarone from clinical trials to real-world evidence: implications for its use in atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Antithrombins; Atrial Fibrillation; Chemical and Drug Induced Liver Injury; Dabigatran; Digoxin; Dronedarone; Drug Interactions; Factor Xa Inhibitors; Heart Failure; Hospitalization; Humans; Mortality; Pyridines; Randomized Controlled Trials as Topic; Thiazoles | 2019 |
Novel oral anticoagulants and stroke prevention in atrial fibrillation and chronic heart failure.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Chronic Disease; Dabigatran; Drug Monitoring; Heart Failure; Hemorrhage; Humans; Morpholines; Outcome Assessment, Health Care; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Severity of Illness Index; Stroke; Thiophenes; Warfarin | 2014 |
Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure: A Meta-Analysis.
Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Cardiovascular Diseases; Cause of Death; Dabigatran; Embolism; Factor Xa Inhibitors; Heart Failure; Hemorrhage; Humans; Intracranial Hemorrhages; Mortality; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2016 |
Atrial fibrillation and heart failure: Factors influencing the choice of oral anticoagulant.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Clinical Decision-Making; Dabigatran; Drug Therapy, Combination; Factor Xa Inhibitors; Heart Failure; Humans; Stroke Volume; Treatment Outcome; Warfarin | 2017 |
Anticoagulation Therapy and NOACs in Heart Failure.
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Heart Failure; Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Venous Thromboembolism; Warfarin | 2017 |
1 trial(s) available for dabigatran and Heart Failure
| Article | Year |
|---|---|
Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trial.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Incidence; Male; Middle Aged; Risk Factors; Stroke; Warfarin | 2013 |
25 other study(ies) available for dabigatran and Heart Failure
| Article | Year |
|---|---|
Dabigatran plasma concentration indicated the risk of patients with non-valvular atrial fibrillation.
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Heart Failure; Hemorrhage; Humans | 2022 |
Direct Oral Anticoagulants in Cardiac Amyloidosis-Associated Heart Failure and Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Amyloidosis; Anticoagulants; Antithrombins; Atrial Fibrillation; Cardiomyopathies; Dabigatran; Factor Xa Inhibitors; Female; Heart Failure; Humans; Male; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Warfarin | 2022 |
Dabigatran for stroke prevention in real life in a sample of population from Turkey: D-SPIRIT registry.
Topics: Age Factors; Aged; Antithrombins; Atrial Fibrillation; Cause of Death; Dabigatran; Diabetes Mellitus; Embolism; Female; Heart Failure; Hemorrhage; Humans; Hypertension; Ischemic Attack, Transient; Male; Myocardial Infarction; Product Surveillance, Postmarketing; Prospective Studies; Registries; Sex Factors; Stroke; Thromboembolism; Turkey | 2021 |
Assessment of Aging-Related Function Variations of P-gp Transporter in Old-Elderly Chinese CHF Patients Based on Modeling and Simulation.
Topics: Adult; Age Factors; Aged; Aging; ATP Binding Cassette Transporter, Subfamily B, Member 1; Computer Simulation; Dabigatran; Digoxin; East Asian People; Heart Failure; Humans; Middle Aged | 2022 |
Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AF.
Topics: Atrial Fibrillation; Dabigatran; Heart Failure; Humans; Prospective Studies; Stroke | 2020 |
Factors influencing cognitive performance after 1-year treatment with direct oral anticoagulant in patients with atrial fibrillation and previous ischemic stroke: a pilot study.
Topics: Aged; Atrial Fibrillation; Cognition; Dabigatran; Dementia; Duration of Therapy; Factor Xa Inhibitors; Female; Heart Failure; Humans; Hyperlipidemias; Ischemic Stroke; Italy; Male; Myocardial Ischemia; Neuropsychological Tests; Prognosis; Risk Factors | 2021 |
Long-Term Risk of Major Adverse Cardiac Events in Atrial Fibrillation Patients on Direct Oral Anticoagulants.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Female; Heart Failure; Humans; Male; Medication Adherence; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Rivaroxaban | 2021 |
Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Heart Failure; Humans; Retrospective Studies; Rivaroxaban; Stroke | 2021 |
Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial).
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Body Mass Index; Coronary Disease; Dabigatran; Diabetes Mellitus; Embolism; Female; Heart Failure; Hemorrhage; Humans; Hypertension; Ischemic Attack, Transient; Male; Medication Adherence; Middle Aged; Polypharmacy; Proportional Hazards Models; Stroke; Warfarin | 2021 |
Ex Vivo Assessment of Different Oral Anticoagulant Regimens on Pump Thrombosis in a HeartWare Ventricular Assist Device.
Topics: Anticoagulants; Blood Coagulation; Dabigatran; Heart Failure; Heart-Assist Devices; Hemolysis; Humans; Platelet Aggregation Inhibitors; Thrombosis; Warfarin | 2021 |
Sex-Specific Associations of Oral Anticoagulant Use and Cardiovascular Outcomes in Patients With Atrial Fibrillation.
Topics: Administration, Oral; Administrative Claims, Healthcare; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cause of Death; Chi-Square Distribution; Dabigatran; Databases, Factual; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Medicare; Multivariate Analysis; Myocardial Infarction; Patient Admission; Propensity Score; Proportional Hazards Models; Retrospective Studies; Risk Factors; Rivaroxaban; Sex Factors; Time Factors; Treatment Outcome; United States; Warfarin | 2017 |
Left ventricular mural thrombus despite treatment with dabigatran and clopidogrel.
Topics: Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Clopidogrel; Dabigatran; Diagnosis, Differential; Drug Therapy, Combination; Dyspnea; Echocardiography; Fatal Outcome; Heart Diseases; Heart Failure; Humans; Male; Thrombosis; Ticlopidine; Warfarin | 2018 |
Idarucizumab for the reversal of dabigatran in patients undergoing heart transplantation.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antithrombins; Atrial Fibrillation; Dabigatran; Dose-Response Relationship, Drug; Drug Substitution; Female; Heart Failure; Heart Transplantation; Humans; Infusions, Intravenous; Male; Middle Aged; Preoperative Period | 2019 |
Letter on 'Idarucizumab for the reversal of dabigatran in patients undergoing heart transplantation'.
Topics: Antibodies, Monoclonal, Humanized; Antithrombins; Dabigatran; Heart Failure; Heart Transplantation; Humans | 2019 |
Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Heart Failure; Humans; Incidence; Kaplan-Meier Estimate; Male; Medicare; Patient Safety; Proportional Hazards Models; Pyrazoles; Pyridones; Retrospective Studies; Risk; Rivaroxaban; Treatment Outcome; United States; Warfarin | 2019 |
[Bleeding in the appointment of dabigatran in the patients with renal insufficiency caused by coadministration of spironolactone and ACE inhibitors].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cardiovascular Agents; Dabigatran; Drug Interactions; Drug Therapy, Combination; Heart Failure; Hemorrhage; Humans; Male; Renal Insufficiency, Chronic; Spironolactone; Treatment Outcome; Withholding Treatment | 2013 |
Placing a value on new technologies.
Topics: Atrial Appendage; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Coronary Occlusion; Dabigatran; Female; Heart Failure; Heart Transplantation; Heart-Assist Devices; Humans; Male; Percutaneous Coronary Intervention; Stroke; Transplantation; Warfarin | 2013 |
Endovascular thrombectomy for acute ischemic stroke patients anticoagulated with dabigatran.
Topics: Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Cerebral Angiography; Dabigatran; Endovascular Procedures; Female; Heart Failure; Humans; Paresis; Stroke; Thrombectomy; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
New oral anticoagulants in heart failure.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Heart Failure; Humans; Male; Stroke; Warfarin | 2013 |
Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Comorbidity; Dabigatran; Denmark; Female; Heart Failure; Humans; Male; Middle Aged; Morpholines; Myocardial Infarction; Myocardial Ischemia; Practice Patterns, Physicians'; Pyrazoles; Pyridones; Registries; Renal Insufficiency, Chronic; Rivaroxaban; Sex Factors; Stroke; Thiophenes; Warfarin | 2015 |
Heart Failure and Mortality in Patients With Nonvalvular Atrial Fibrillation Started on Novel Oral Anticoagulant Therapy: A Single-Center Experience.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Disease-Free Survival; Female; Heart Failure; Humans; Male; Middle Aged; Survival Rate; Thromboembolism | 2017 |
Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment.
Topics: Aged; Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Female; Glomerular Filtration Rate; Heart Failure; Humans; Male; Middle Aged; Pyrazoles; Pyridines; Pyridones; Renal Insufficiency, Chronic; Rivaroxaban; Severity of Illness Index; Stroke; Thiazoles | 2016 |
Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Clopidogrel; Dabigatran; Diabetes Mellitus; Female; Guideline Adherence; Heart Failure; Humans; Hypertension; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk; Risk Assessment; Stroke; Ticlopidine; United States; United States Department of Veterans Affairs; Warfarin | 2016 |
Dabigatran overdose: a case report of acute hepatitis. Extracorporeal treatment.
Topics: Acute Disease; Aged; Atrial Fibrillation; Coma; Dabigatran; Drug Overdose; Heart Failure; Hemodiafiltration; Hepatitis; Humans; Male; Renal Insufficiency, Chronic; Stroke | 2017 |
[Update in hospital internal medicine (2007): a selection].
Topics: Anti-Bacterial Agents; Anticoagulants; Benzimidazoles; Bone Density Conservation Agents; Community-Acquired Infections; Coronary Disease; Dabigatran; Defibrillators, Implantable; Diabetes Mellitus, Type 2; Fractures, Bone; Heart Failure; Heart Neoplasms; Hip Prosthesis; Hospital Departments; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Internal Medicine; Liver Cirrhosis; Oligosaccharides; Osteoporosis; Peritonitis; Pneumonia, Bacterial; Pulmonary Embolism; Pyridines; Quality of Health Care; Risk Factors; Stroke; Teaching; Tomography, X-Ray Computed; Venous Thrombosis | 2008 |